Rocket Lab Corporation $RKLB Stock Acquired by ProShare Advisors LLC

ProShare Advisors LLC grew its holdings in Rocket Lab Corporation (NASDAQ:RKLB) by 7.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 578,195 shares of the rocket manufacturer’s stock after acquiring an additional 40,197 shares during the period. ProShare Advisors LLC’s holdings in Rocket Lab were worth $40,289,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in RKLB. BlackRock Inc. bought a new stake in Rocket Lab during the 2nd quarter valued at approximately $4,124,970,000. Bank of New York Mellon Corp purchased a new stake in Rocket Lab during the 2nd quarter valued at approximately $245,764,000. Bank of America Corp DE bought a new stake in shares of Rocket Lab during the second quarter valued at approximately $437,280,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Rocket Lab by 14.8% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,737,451 shares of the rocket manufacturer’s stock valued at $278,262,000 after buying an additional 352,094 shares during the last quarter. Finally, Amundi raised its position in shares of Rocket Lab by 22.2% during the second quarter. Amundi now owns 2,180,748 shares of the rocket manufacturer’s stock valued at $221,673,000 after buying an additional 396,639 shares during the last quarter. Institutional investors own 71.78% of the company’s stock.

Analyst Ratings Changes

RKLB has been the subject of several research analyst reports. Raymond James Financial began coverage on Rocket Lab in a report on Friday, September 11th. They set an “outperform” rating and a $80.00 price target for the company. Morgan Stanley reaffirmed an “overweight” rating on shares of Rocket Lab in a report on Wednesday, July 8th. Needham & Company LLC reiterated a “buy” rating and set a $120.00 target price on shares of Rocket Lab in a research report on Friday, October 16th. Piper Sandler started coverage on shares of Rocket Lab in a report on Wednesday, July 15th. They issued a “neutral” rating and a $83.00 target price for the company. Finally, Wall Street Zen cut shares of Rocket Lab from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. Three investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $102.05.

Key Rocket Lab News

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab continues to make operational progress: Neutron’s second stage and thrust module have reached Wallops Island, Virginia, for ground testing, while the company is preparing to ship its 100th Electron rocket. These milestones suggest development is advancing despite the launch delay. RKLB Stock Tests Bulls’ Patience
• Positive Sentiment: Analysts and bullish investors continue to point to Rocket Lab’s expanding business, including strong revenue growth, a reported $2.36 billion backlog, NASA-related opportunities, Iridium work and Mynaric exposure. Some forecasts argue that a successful Neutron milestone could eventually prompt a significant re-rating toward $100. Price Prediction: Rocket Lab Stock Will Hit $100
• Neutral Sentiment: The bullish investment thesis remains intact for some investors, but the Neutron delay changes the expected timing of revenue, launches and potential profitability. Rocket Lab’s substantial cash position and low leverage provide flexibility, though its high-growth valuation leaves the stock sensitive to schedule changes. The Neutron Delay Changes the Timeline, Not the Thesis
• Negative Sentiment: Investors are concerned that manufacturing defects in Neutron’s carbon-fiber structures—likened to trapped bubbles in a layered cake—contributed to the schedule slip. The delay increases execution risk and could lead to additional spending or dilution if development takes longer than expected. Rocket Lab Stock Lost Its Launch Date
• Negative Sentiment: An analyst fair-value estimate was trimmed from approximately $105.05 to $102.15, reflecting lower near-term expectations and greater execution risk following the Neutron delay. With Rocket Lab still unprofitable, investors are placing greater emphasis on delivery milestones rather than current earnings. Rocket Lab Fair Value Trim After Neutron Delay

Insider Activity

In related news, insider Frank Klein sold 45,692 shares of the stock in a transaction on Monday, August 24th. The stock was sold at an average price of $69.63, for a total transaction of $3,181,533.96. Following the sale, the insider owned 961,295 shares in the company, valued at approximately $66,934,970.85. This represents a 4.54% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Agostino Ricupati sold 669 shares of Rocket Lab stock in a transaction on Monday, August 24th. The stock was sold at an average price of $69.63, for a total transaction of $46,582.47. Following the transaction, the chief accounting officer directly owned 26,863 shares of the company’s stock, valued at $1,870,470.69. The trade was a 2.43% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders have sold 400,749 shares of company stock worth $26,964,474. Company insiders own 8.40% of the company’s stock.

Rocket Lab Stock Performance

RKLB opened at $54.73 on Monday. The stock has a 50-day moving average of $64.23 and a 200 day moving average of $79.93. The company has a current ratio of 5.48, a quick ratio of 4.98 and a debt-to-equity ratio of 0.01. Rocket Lab Corporation has a 12 month low of $37.57 and a 12 month high of $151.00. The firm has a market cap of $32.75 billion, a P/E ratio of -202.70 and a beta of 3.15.

Rocket Lab (NASDAQ:RKLB) last issued its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.02). The company had revenue of $234.07 million for the quarter, compared to analysts’ expectations of $231.62 million. Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. As a group, research analysts forecast that Rocket Lab Corporation will post -0.20 EPS for the current year.

Rocket Lab Company Profile

Rocket Lab USA, Inc is a space and defense company that develops and operates launch vehicles, spacecraft, satellite components and related space systems. The company serves government, commercial and scientific customers seeking access to orbit and other space-based capabilities.

Rocket Lab’s launch business is centered on Electron, a small orbital launch vehicle designed to carry satellites and other payloads into low Earth orbit. The company also develops specialized launch and hypersonic test services through programs such as HASTE, while its Neutron vehicle is intended to provide larger payload capacity and support future commercial and government missions.

Through its space systems business, Rocket Lab produces satellite platforms, flight computers, power systems, solar cells, reaction wheels, separation systems, radios and other components used in spacecraft.